secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001654954-25-012575
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica Q3 2025 revenue $8.1M (+16% YoY); net loss narrows to $6.1M
--------------------------------------------------------------------

- Revenue $8.1M, up 16% YoY; gross margin 67%; Diagnostics segment grew 51%.
- Net loss $6.1M (down 9% YoY); adjusted EBITDA loss $3.9M.
- Cash and securities $54.4M; operating expenses reduced $0.5M in Q3.
- New Development Services segment generated $0.7M revenue in first quarter.
- Record revenue for 19th straight quarter; new distribution agreements in UK, Netherlands, Canada.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495425012575/0001654954-25-012575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495425012575/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-012575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer